R&D PIPELINE

In addition to Mesothelioma, Disulfican's work also addresses translation of disulfiram for treatment of other aggressive cancers such as Glioblastoma, Pancreatic cancer, Non-small cell lung cancer and Multiple Myeloma. Disulfican has developed a very promising proof of concept results using animal models and patient derived primary cells for these cancers. Disulfican also works on developing a proprietary formulation pipeline for Disulfiram and its derivatives that can be used effectively on different cancers based on different route of administration.